Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02457988 · ClinicalTrials.gov registry record · Early Phase 1
The Cirrhosis Outpatient Optimization, Readmission & Safety Study
A Early Phase 1 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 120
- Enrollment target
NCT02457988 is a Early Phase 1 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 120 participants.
The verdict
NCT02457988, a Early Phase 1 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 120 participants
- Enrollment target
Study Summary
A prospective series comparing care incorporating home monitoring and liver care coordination to conventional care for patients with cirrhosis.
Interventions
- DEVICE Vivify Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02457988
The ClinicalTrials.gov registry entry for NCT02457988 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vivify Kit is the first listed.
NCT02457988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02457988 about?
NCT02457988 is a clinical study titled "The Cirrhosis Outpatient Optimization, Readmission & Safety Study". A prospective series comparing care incorporating home monitoring and liver care coordination to conventional care for patients with cirrhosis.
What is the current status of trial NCT02457988?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 120 participants. The study started on 2015-04. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02457988?
The interventions under investigation include: Vivify Kit (DEVICE).
Who is sponsoring clinical trial NCT02457988?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.